{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T02:49:20Z","timestamp":1793674160051,"version":"4.5.1"},"reference-count":55,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T00:00:00Z","timestamp":1675036800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012484","name":"University of Michigan Center for Gastrointestinal Research","doi-asserted-by":"publisher","award":["5 P30 DK034933"],"award-info":[{"award-number":["5 P30 DK034933"]}],"id":[{"id":"10.13039\/100012484","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008269","name":"Michigan Institute for Clinical and Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01DK120623"],"award-info":[{"award-number":["R01DK120623"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1TR002240"],"award-info":[{"award-number":["UL1TR002240"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.jhep.2023.01.019","type":"journal-article","created":{"date-parts":[[2023,2,3]],"date-time":"2023-02-03T01:55:19Z","timestamp":1675389319000},"page":"998-1006","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":198,"title":["A human liver organoid screening platform for DILI risk prediction"],"prefix":"10.1016","volume":"78","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0300-849X","authenticated-orcid":false,"given":"Charles J.","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7301-8370","authenticated-orcid":false,"given":"Sophia R.","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"O\u2019Meara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sha","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghan M.","family":"Capeling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daysha","family":"Ferrer-Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlie J.","family":"Childs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason R.","family":"Spence","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Fontana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9244-5888","authenticated-orcid":false,"given":"Jonathan Z.","family":"Sexton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2023.01.019_bib1","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2165\/00002018-200932010-00005","article-title":"Drug-Induced Liver Injury Network (DILIN) prospective study: rationale, design and conduct","volume":"32","author":"Fontana","year":"2009","journal-title":"Drug Saf"},{"key":"10.1016\/j.jhep.2023.01.019_bib2","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/hep.23696","article-title":"Standardization of nomenclature and causality assessment in drug-induced liver injury: summary of a clinical research workshop","volume":"52","author":"Fontana","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2023.01.019_bib3","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/0009-9236(95)90078-0","article-title":"Drug safety discontinuations in the United Kingdom, the United States, and Spain from 1974 through 1993: a regulatory perspective","volume":"58","author":"Bakke","year":"1995","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jhep.2023.01.019_bib4","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/clpt.2011.63","article-title":"Drug safety sciences and the bottleneck in drug development","volume":"89","author":"Watkins","year":"2011","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jhep.2023.01.019_bib5","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/hep.28813","article-title":"Liver injury from herbal and dietary supplements","volume":"65","author":"Navarro","year":"2017","journal-title":"Hepatol"},{"key":"10.1016\/j.jhep.2023.01.019_bib6","doi-asserted-by":"crossref","first-page":"S509","DOI":"10.1016\/S0168-8278(18)31267-4","article-title":"Dose response and safety of the daily, oral RIG-I agonist Inarigivir (SB 9200) in treatment na\u00efve patients with chronic hepatitis B: results from the 25mg and 50mg cohorts in the ACHIEVE trial [Internet]","volume":"68","author":"Yuen","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2023.01.019_bib7","series-title":"Liver toxicity in the Phase 2 Catalyst 206 trial of inarigivir 400mg daily added to a nucleos(t)ide in HBeAg negative patients","author":"Agarwal","year":"2020"},{"key":"10.1016\/j.jhep.2023.01.019_bib8","series-title":"A phase 2, open-label, randomized, multiple dose study evaluating Inarigivir in treatment-na\u00efve patients with chronic hepatitis B. Liver [Internet]","author":"Yuen","year":"2022"},{"key":"10.1016\/j.jhep.2023.01.019_bib9","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1089\/ten.tec.2011.0629","article-title":"Effect of Oxygen Concentration on Viability and Metabolism in a Fluidized-Bed Bioartificial Liver Using 31P and 13C NMR Spectroscopy","volume":"19","author":"Jeffries","year":"2013","journal-title":"Tissue Eng. Part C Methods."},{"key":"10.1016\/j.jhep.2023.01.019_bib10","first-page":"1","article-title":"Hepatocyte cryopreservation: is it time to change the strategy?","volume":"16","author":"St\u00e9phenne","year":"2010","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.jhep.2023.01.019_bib11","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.cmet.2019.05.007","article-title":"Modeling steatohepatitis in humans with pluripotent stem cell-derived organoids","volume":"30","author":"Ouchi","year":"2019","journal-title":"Cell Metab"},{"key":"10.1016\/j.jhep.2023.01.019_bib12","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/bs.mcb.2020.03.009","article-title":"Generation of multi-cellular human liver organoids from pluripotent stem cells","volume":"159","author":"Thompson","year":"2020","journal-title":"Methods Cell Biol"},{"key":"10.1016\/j.jhep.2023.01.019_bib13","article-title":"Bone-chip system to monitor osteogenic differentiation using optical imaging.","volume":"23","author":"Sheyn","year":"2019","journal-title":"Microfluid. Nanofluidics [Internet]"},{"key":"10.1016\/j.jhep.2023.01.019_bib14","first-page":"11","article-title":"Reproducing human and cross-species drug toxicities using a Liver-Chip","author":"Jang","year":"2019","journal-title":"Sci Transl Med [Internet]"},{"key":"10.1016\/j.jhep.2023.01.019_bib15","article-title":"Qualifying a human Liver-Chip for predictive toxicology: Performance assessment and economic implications [Internet]","author":"Ewart","year":"2021","journal-title":"bioRxiv"},{"key":"10.1016\/j.jhep.2023.01.019_bib16","series-title":"Liver-Chip Co-Culture Protocol [Internet]","year":"2019"},{"key":"10.1016\/j.jhep.2023.01.019_bib17","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nature13863","article-title":"Modelling human development and disease in pluripotent stem-cell-derived gastric organoids","volume":"516","author":"McCracken","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2023.01.019_bib18","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1002\/dneu.22816","article-title":"STRADA-mutant human cortical organoids model megalencephaly and\u00a0exhibit delayed neuronal differentiation","volume":"81","author":"Dang","year":"2021","journal-title":"Dev Neurobiol."},{"key":"10.1016\/j.jhep.2023.01.019_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0150372","article-title":"Genomic Instability Associated with p53 Knockdown in the Generation of Huntington\u2019s Disease Human Induced Pluripotent Stem Cells","volume":"11","author":"Tidball","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2023.01.019_bib20","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1038\/nprot.2011.410","article-title":"Generating human intestinal tissue from pluripotent stem cells in vitro","volume":"6","author":"McCracken","year":"2011","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.jhep.2023.01.019_bib21","doi-asserted-by":"crossref","first-page":"R100","DOI":"10.1186\/gb-2006-7-10-r100","article-title":"CellProfiler: image analysis software for identifying and quantifying cell phenotypes","volume":"7","author":"Carpenter","year":"2006","journal-title":"Genome Biol"},{"key":"10.1016\/j.jhep.2023.01.019_bib22","article-title":"Dimensionality reduction for visualizing single-cell data using UMAP","author":"Becht","year":"2018","journal-title":"Nat Biotechnol [Internet]"},{"key":"10.1016\/j.jhep.2023.01.019_bib23","doi-asserted-by":"crossref","first-page":"205","DOI":"10.21105\/joss.00205","article-title":"hdbscan: Hierarchical density based clustering","volume":"2","author":"McInnes","year":"2017","journal-title":"J Open Source Softw"},{"key":"10.1016\/j.jhep.2023.01.019_bib24","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/hep.26175","article-title":"LiverTox: a website on drug-induced liver injury","volume":"57","author":"Hoofnagle","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2023.01.019_bib25","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41575-019-0244-5","article-title":"Multispecies liver-on-a-chip for improved drug toxicity testing","volume":"17","author":"Dickson","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2023.01.019_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1386-6346(03)00115-3","article-title":"Connective tissue growth factor (CTGF\/CCN2) in hepatic fibrosis","volume":"26","author":"Rachfal","year":"2003","journal-title":"Hepatol Res"},{"key":"10.1016\/j.jhep.2023.01.019_bib27","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1186\/s13287-019-1367-x","article-title":"Adult and iPS-derived non-parenchymal cells regulate liver organoid development through differential modulation of Wnt and TGF-\u03b2","volume":"10","author":"Goulart","year":"2019","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.jhep.2023.01.019_bib28","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.yexmp.2015.03.033","article-title":"Intestinal organoids: a model of intestinal fibrosis for evaluating anti-fibrotic drugs","volume":"98","author":"Rodansky","year":"2015","journal-title":"Exp Mol Pathol"},{"key":"10.1016\/j.jhep.2023.01.019_bib29","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.jhep.2020.11.025","article-title":"NNMT aggravates hepatic steatosis, but alleviates liver injury in alcoholic liver disease","volume":"74","author":"Ding","year":"2021","journal-title":"J Hepatol."},{"key":"10.1016\/j.jhep.2023.01.019_bib30","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3389\/fendo.2018.00117","article-title":"IGF-Binding Proteins: Why Do They Exist and Why Are There So Many?","volume":"9","author":"Allard","year":"2018","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.jhep.2023.01.019_bib31","first-page":"817","article-title":"The past and present of serum aminotransferases and the future of liver injury biomarkers","volume":"15","author":"McGill","year":"2016","journal-title":"EXCLI J"},{"key":"10.1016\/j.jhep.2023.01.019_bib32","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.jhep.2019.02.014","article-title":"Electronic address: easloffice@easloffice.eu, Clinical Practice Guideline Panel: Chair:, Panel members, EASL Governing Board representative: EASL Clinical Practice Guidelines: Drug-induced liver injury","volume":"70","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2023.01.019_bib33","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1124\/dmd.108.026195","article-title":"Pharmacokinetics of acetaminophen-protein adducts in adults with acetaminophen overdose and acute liver failure","volume":"37","author":"James","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.jhep.2023.01.019_bib34","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1073\/pnas.81.5.1327","article-title":"N-acetyl-p-benzoquinone imine: a cytochrome P-450-mediated oxidation product of acetaminophen","volume":"81","author":"Dahlin","year":"1984","journal-title":"Proc Natl Acad Sci U S A."},{"key":"10.1016\/j.jhep.2023.01.019_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00002018-199717010-00001","article-title":"Mitochondrial Injury Lessons from the Fialuridine Trial [Internet]","volume":"17","author":"Honkoop","year":"1997","journal-title":"Drug Safety"},{"key":"10.1016\/j.jhep.2023.01.019_bib36","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/S0168-8278(00)00106-9","article-title":"Mitochondria: important target for drug toxicity?","volume":"34","author":"Kr\u00e4henb\u00fchl","year":"2001","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2023.01.019_bib37","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/978-3-642-00663-0_12","article-title":"Mechanisms of acetaminophen-induced liver necrosis","author":"Hinson","year":"2010","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.jhep.2023.01.019_bib38","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.gtc.2017.01.004","article-title":"Drug-induced liver injury: The hepatic pathologist\u2019s approach","volume":"46","author":"Kleiner","year":"2017","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1016\/j.jhep.2023.01.019_bib39","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1128\/AAC.48.1.124-129.2004","article-title":"Single-dose and steady-state pharmacokinetics of tenofovir disoproxil fumarate in human immunodeficiency virus-infected children","volume":"48","author":"Hazra","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jhep.2023.01.019_bib40","unstructured":"A Fixed-Sequence, Drug-Drug Interaction Study Between Multiple Oral Doses of Inarigivir Soproxil and a Single Oral Dose of Midazolam in Healthy Subjects [Internet]. [cited 2022 Jul 19]; Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03493698."},{"key":"10.1016\/j.jhep.2023.01.019_bib41","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s11010-020-03863-y","article-title":"LncRNA KCNQ1OT1 ameliorates the liver injury induced by acetaminophen through the regulation of miR-122-5p\/CES2 axis","volume":"475","author":"Pei","year":"2020","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.jhep.2023.01.019_bib42","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1002\/hep.22980","article-title":"Specific role for acyl CoA:Diacylglycerol acyltransferase 1 (Dgat1) in hepatic steatosis due to exogenous fatty acids","volume":"50","author":"Villanueva","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2023.01.019_bib43","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1096\/fasebj.31.1_supplement.458.3","article-title":"Role of Hepatic PLIN2 and PLIN4 in The Development of Western Type Diet Induced Hepatosteatosis","volume":"31","author":"Griffin","year":"2017","journal-title":"FASEB J"},{"key":"10.1016\/j.jhep.2023.01.019_bib44","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.ajpath.2018.01.012","article-title":"Fatty Acid Binding Protein 4 (FABP4) Overexpression in Intratumoral Hepatic Stellate Cells within Hepatocellular Carcinoma with Metabolic Risk Factors [Internet]","volume":"188","author":"Chiyonobu","year":"2018","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jhep.2023.01.019_bib45","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1111\/liv.13639","article-title":"Altered fatty acid-binding protein 4 (FABP4) expression and function in human and animal models of hepatocellular carcinoma","volume":"38","author":"Thompson","year":"2018","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2023.01.019_bib46","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1038\/s41388-018-0597-1","article-title":"Endothelial fatty liver binding protein 4: a new targetable mediator in hepatocellular carcinoma related to metabolic syndrome","volume":"38","author":"Laouirem","year":"2019","journal-title":"Oncogene"},{"key":"10.1016\/j.jhep.2023.01.019_bib47","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/ijo.2010.128","article-title":"RNAi-mediated germline knockdown of FABP4 increases body weight but does not improve the deranged nutrient metabolism of diet-induced obese mice","volume":"35","author":"Yang","year":"2011","journal-title":"Int J Obes"},{"key":"10.1016\/j.jhep.2023.01.019_bib48","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3109\/03602532.2011.604086","article-title":"Central role of mitochondria in drug-induced liver injury","volume":"44","author":"Pessayre","year":"2012","journal-title":"Drug Metab Rev"},{"key":"10.1016\/j.jhep.2023.01.019_bib49","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/pin.12634","article-title":"Peroxiredoxin 4 (PRDX4): Its critical in vivo roles in animal models of metabolic syndrome ranging from atherosclerosis to nonalcoholic fatty liver disease [Internet]","volume":"68","author":"Yamada","year":"2018","journal-title":"Pathol Int"},{"key":"10.1016\/j.jhep.2023.01.019_bib50","doi-asserted-by":"crossref","first-page":"683","DOI":"10.7150\/ijms.5947","article-title":"Glutathione S-transferase P1 correlated with oxidative stress in hepatocellular carcinoma","volume":"10","author":"Li","year":"2013","journal-title":"Int J Med Sci"},{"key":"10.1016\/j.jhep.2023.01.019_bib51","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1053\/j.gastro.2020.10.002","article-title":"High-Fidelity Drug-Induced Liver Injury Screen Using Human Pluripotent\u00a0Stem Cell\u2013Derived Organoids","volume":"160","author":"Shinozawa","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2023.01.019_bib52","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1038\/nprot.2016.105","article-title":"Cell Painting, a high-content image-based assay for morphological profiling using multiplexed fluorescent dyes","volume":"11","author":"Bray","year":"2016","journal-title":"Nat Protoc"},{"key":"10.1016\/j.jhep.2023.01.019_bib53","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1310\/B5VU-FU5F-QNWC-UDCK","article-title":"Pharmacokinetics of nevirapine: once-daily versus twice-daily dosing in the 2NN study","volume":"6","author":"Kappelhoff","year":"2005","journal-title":"HIV Clin Trials"},{"key":"10.1016\/j.jhep.2023.01.019_bib54","doi-asserted-by":"crossref","first-page":"12063","DOI":"10.1074\/jbc.271.20.12063","article-title":"Role of CYP2E1 in the Hepatotoxicity of Acetaminophen [Internet]","volume":"271","author":"Lee","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2023.01.019_bib55","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1126\/science.1151526","article-title":"Induced pluripotent stem cell lines derived from human somatic cells","volume":"318","author":"Yu","year":"2007","journal-title":"Science"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827823000727?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827823000727?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:56:31Z","timestamp":1777510591000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827823000727"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":55,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S0168827823000727"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2023.01.019","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.08.26.457824","asserted-by":"object"}]},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A human liver organoid screening platform for DILI risk prediction","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2023.01.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier B.V. on behalf of European Association for the Study of the Liver.","name":"copyright","label":"Copyright"}]}}